Three quarters of a mile from civilization
Views, analysis & commentary - essentially on venture capital & pharmaceutical industry
Showing posts with label
Big Pharma
.
Show all posts
Showing posts with label
Big Pharma
.
Show all posts
Monday, December 22, 2014
Big Idea 2015: Haute Apothicaire
›
There are medicines & then there is Haute Apothicaire From what’s written on the wall, 2015 could well be the year when goo...
Thursday, November 7, 2013
Les Propheties Pharmaceuticale : Prophesying on where the pharmaceutical outsourcing is headed
›
It is either an after-effect of all that powwow with the old-worldly Chippewa ( the ‘real-Indians’, who aren’t Indian really ;-) ) in the ...
Wednesday, August 28, 2013
Isn't re-coding the organizational DNA viable only for smaller set-ups?
›
Bruce Booth makes some really radical suggestions to altering the way a big-pharma R&D set-up could work, primarily by way of re-codi...
Tuesday, March 5, 2013
What could VCs learn from the recent pharma deals involving biotechs with very early-assets?
›
My response on the blog post " Preclinical Biotech Structured Deals: Reflections on 2013′s Solid Start" by Bruce Booth - post...
Thursday, January 24, 2013
Is the LP bias against investment into life-sciences contra-logical?
›
17 January 2013 Early Stage Biotech Showing Positive Signs of Scaling Its Wall of Worry by Bruce Booth on Forbes http://www.fo...
1 comment:
›
Home
View web version
.jpg)
